Interestingly, evidence shows that ADAM10 levels are reduced in the cerebrospinal fluid (CSF) of AD patients, suggesting a natural inhibitor of the enzyme might be present in the pathology [41]. The gene discussed is ADAM10; the disease is Alzheimer disease.